End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,590 KRW | -0.65% | -5.01% | +36.51% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 183 | 100.0 % | 334 | 100.0 % | +82.12% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 159 | 86.7 % | 334 | 100.0 % | +109.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Hwa-Sub Choi
DFI | Director of Finance/CFO | 50 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Jae-Seung Sim
AUD | Comptroller/Controller/Auditor | 65 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Wan-Gyun Jung
BRD | Director/Board Member | 65 | - |
Hwa-Sub Choi
DFI | Director of Finance/CFO | 50 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,401,272 | 4,057,400 ( 48.30 %) | 85 ( 0.001012 %) | 48.30 % |
Company contact information
Femtobiomed, Inc.
Unit301, Pangyo Seven Valley 2 17, Pangyo-ro 228beon-gil
13487, Seongnam-si
+
http://www.femtobiomed.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+36.51% | 45.35M | |
+17.09% | 44.63B | |
+46.06% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+44.11% | 14.06B | |
+32.33% | 12.54B | |
-7.26% | 11.28B |
- Stock Market
- Equities
- A327610 Stock
- Company Femtobiomed Inc.